Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06114056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06114056 · ClinicalTrials.gov record · last posted 2026-03-17

A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)

Name: A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD) — clinical trial record (NCT06114056)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 1

SponsorWest China Hospital

Started2024-01-31

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study is a single-center, single-arm, non-randomized, open-label, non-controlled, dose-escalation, prospective clinical trial designed to assess the safety, tolerability, and preliminary efficacy of JWK007 injection in pediatric patients with Duchenne Muscular Dystrophy (DMD).

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2023-10-29; most recent amendment 2026-03-15. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-06-15

Status change Recruiting→Active, Not Recruitingv2

Trial Details

NCT Number	NCT06114056
Lead Sponsor	West China Hospital
Conditions	Duchenne Muscular Dystrophy
Enrollment	3 participants
Start Date	2024-01-31
Primary Completion	2029-11-13 (estimated)
Study Completion	2029-11-13 (estimated)
Updated on ClinicalTrials.gov	2026-03-17